New meningitis A vaccine is a “breakthrough” for 430 million people at riskBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3552 (Published 02 July 2010) Cite this as: BMJ 2010;341:c3552
- Peter Moszynski
The approval by the World Health Organization of a low cost vaccine against meningitis has been hailed by the charity Médecins Sans Frontières as a move “full of promise” for the 430 million people at risk of the disease in the meningitis belt of sub-Saharan Africa.
Cathy Hewison, the charity’s medical adviser, told the BMJ that the new vaccine, called MenAfriVac, could virtually eliminate the epidemic form of the disease but warned that the full rollout of this “much needed vaccine” depends on sufficient funds being mobilised. Médecins Sans Frontières has been leading the Campaign for Access to Essential Medicines.
Dr Hewison said the existing vaccine “confers very short term protection, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial